Intensive Care NursesNCT07471152
The Effect of Virtual Reality Goggles on Perceived Stress, Anxiety, and Fatigue in Nurses Working in Intensive Care Units
A study testing virtual reality glasses in people with Intensive Care Nurses, run by Firat University at 1 site in Turkey (Türkiye).
Trial summary
This study aims to evaluate the effect of a Virtual Reality (VR)-based relaxation intervention on perceived stress, anxiety, and fatigue levels among intensive care unit (ICU) nurses. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Intensive Care Nurses
- What is being tested?
- virtual reality glasses
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jul 2025to 1 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- • Being 18 years of age or older
- Actively working in the intensive care unit of the relevant hospital for at least six months,
- Working on an alternating shift basis (such as 24-hour work - 24-hour rest) during the research period,
Who cannot join
- Having neurological disorders (epilepsy, migraine, vertigo, etc.) that may cause loss of balance or severe nausea during the virtual reality application,
- Being required to wear prescription glasses due to the technical structure of the VR headset (physical compatibility of the device),
- Having previously experienced any virtual reality (VR) application
Trial locations and contacts
1 site in 1 country.
About this study
This study aims to evaluate the effect of a Virtual Reality (VR)-based relaxation intervention on perceived stress, anxiety, and fatigue levels among intensive care unit (ICU) nurses. The ICU environment is characterized by high-intensity workloads and emotional demands, which often lead to increased psychological and physical strain on nursing staff
- Conditions
- Intensive Care Nurses
- Being tested
- virtual reality glasses
- Keywords
- Virtual Reality Glasses
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
virtual reality glassesBehavioural
The group that made the virtual reality headset
| Study group | Role | What they receive |
|---|---|---|
| Experiment Group | Experimental | Virtual Reality Glasses Group Receives: Behavioral: virtual reality glasses |
| Control group | No intervention | the group that did not make virtual reality glasses |
What is being measured
The primary outcome is the main question the study is designed to answer.
The Perceived Stress Scale-10
Developed to assess the level of stress individuals have perceived in their lives over the past month. The scale, developed by Sheldon Cohen et al., consists of 10 items. It is a 5-point Likert scale, with items scored from "0=Never" to "4=Very often". Items 4, 5, 7, and 8 are reverse-scored. The total score obtainable from the scale ranges from 0 to 40, with higher scores indicating a high level of perceived stress. The Turkish validity and reliability study of the scale was conducted by Ersin Eskin et al.
Measured: after the 3 consecutive days of intervention
State Anxiety Scale
The State Anxiety Scale developed by Spielberger et al. aims to measure the level of anxiety experienced by individuals at a specific time and under specific conditions. Validity and reliability studies of the scale in Turkey were conducted by Öner and Le Comte (Öner and Le Comte, 1983). The SAS consists of 20 items and is designed to assess situational anxiety. The scale has a 4-point Likert-type response format, with scores ranging from 20 to 80; higher scores indicate higher levels of anxiety. The Cronbach alpha coefficient of the SAS in the original study was found to be 0.94 (Öner and Le Comte, 1983). In this study, the Cronbach alpha coefficient was found to be 0.93.
Measured: after the 3 consecutive days of intervention
Fatigue Severity Scale
Developed to assess the impact and severity of fatigue on daily life in individuals. The scale was developed by Krupp et al. Consisting of 9 items, the scale uses a 7-point Likert scale, with items scored between 1 (strongly disagree) and 7 (strongly agree). The total score or item mean obtained from the scale indicates the severity of fatigue; higher scores indicate a higher level of fatigue. The Turkish validity and reliability study of the scale was conducted by Armutlu et al.
Measured: after the 3 consecutive days of intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Mar 2026
- Study start1 Jul 2025
- Primary completion1 Sep 2025
- Study completion1 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Intensive Care NursesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Firat University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gülcan Bahçecioğlu Turan, Firat University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07471152
- Sponsor's protocol ID
- 2024/03-21
- Status last verified
- Mar 2026
- First submitted
- 9 Mar 2026
- Last updated
- 13 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Virtual Reality Goggles on Perceived Stress, Anxiety, and Fatigue in Nurses Working in Intensive Care Units
- ClinicalTrials.gov ID
- NCT07471152
- Acronym / sponsor ID
- 2024/03-21
- Conditions
- Intensive Care Nurses
- Keywords
- Virtual Reality Glasses
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Firat UniversityUniversity, hospital or other
- Study start
- 1 Jul 2025 (actual)
- Primary completion
- 1 Sep 2025 (actual)
- Study completion
- 1 Dec 2025 (actual)
- First posted
- 13 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the effect of a Virtual Reality (VR)-based relaxation intervention on perceived stress, anxiety, and fatigue levels among intensive care unit (ICU) nurses. The ICU environment is characterized by high-intensity workloads and emotional demands, which often lead to increased psychological and physical strain on nursing staff
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experiment Group | Experimental | Behavioral: virtual reality glassesVirtual Reality Glasses Group |
| Control group | No intervention | –the group that did not make virtual reality glasses |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- • Being 18 years of age or older
Key exclusion criteria (3 listed)
- Having neurological disorders (epilepsy, migraine, vertigo, etc.) that may cause loss of balance or severe nausea during the virtual reality application,
- Being required to wear prescription glasses due to the technical structure of the VR headset (physical compatibility of the device),
- Having previously experienced any virtual reality (VR) application
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| virtual reality glassesThe group that made the virtual reality headset | Behavioural | Experiment Group |
Primary outcome
The Perceived Stress Scale-10
Time frame: after the 3 consecutive days of intervention
Developed to assess the level of stress individuals have perceived in their lives over the past month. The scale, developed by Sheldon Cohen et al., consists of 10 items. It is a 5-point Likert scale, with items scored from "0=Never" to "4=Very often". Items 4, 5, 7, and 8 are reverse-scored. The total score obtainable from the scale ranges from 0 to 40, with higher scores indicating a high level of perceived stress. The Turkish validity and reliability study of the scale was conducted by Ersin Eskin et al.
State Anxiety Scale
Time frame: after the 3 consecutive days of intervention
The State Anxiety Scale developed by Spielberger et al. aims to measure the level of anxiety experienced by individuals at a specific time and under specific conditions. Validity and reliability studies of the scale in Turkey were conducted by Öner and Le Comte (Öner and Le Comte, 1983). The SAS consists of 20 items and is designed to assess situational anxiety. The scale has a 4-point Likert-type response format, with scores ranging from 20 to 80; higher scores indicate higher levels of anxiety. The Cronbach alpha coefficient of the SAS in the original study was found to be 0.94 (Öner and Le Comte, 1983). In this study, the Cronbach alpha coefficient was found to be 0.93.
Fatigue Severity Scale
Time frame: after the 3 consecutive days of intervention
Developed to assess the impact and severity of fatigue on daily life in individuals. The scale was developed by Krupp et al. Consisting of 9 items, the scale uses a 7-point Likert scale, with items scored between 1 (strongly disagree) and 7 (strongly agree). The total score or item mean obtained from the scale indicates the severity of fatigue; higher scores indicate a higher level of fatigue. The Turkish validity and reliability study of the scale was conducted by Armutlu et al.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Intensive Care Nurses
Enrolling by invitationObservational study
The Impact of Professional Holistic Competence, Professional Pride, and Organizational Spirituality on Quiet Quitting Among Intensive Care Nurses
Intensive Care (ICU), Quitting
Recruiting
Impact on Prognosis of Increased Sleep Quality Obtained by Personalized Night-time Nursing Care in Critically Ill Patients
Intensive Care Unit (ICU), Sleep Disruption
Recruiting
Case-Based Collaborative Learning for Arrhythmia Recognition in Novice Intensive Care Nurses
Arrhythmia Recognition, Patient Safety Attitudes
Not yet recruitingObservational study
Perceptions of Leadership in Quality Culture for Infection Prevention Among Intensive Care Nurses and Unit-Based Assessment of Antimicrobial Resistance Indicators in Intensive Care Units
Healthcare-associated Infections, Quality Culture and Leadership in Intensive Care
Not yet recruitingObservational study
Hand Hygiene Compliance and Bacterial Colonization on Personal Belongings
Intensive Care Nurses, Bacterial Colonization
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing virtual reality glasses in people with Intensive Care Nurses, run by Firat University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The Perceived Stress Scale-10 (time frame: after the 3 consecutive days of intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2026.